Main cardiac complications in patients with Post COVID-19 Syndrome
DOI:
https://doi.org/10.56294/saludcyt2022203Keywords:
COVID-19, SARS-CoV-2, Cardiovascular Complications, Post COVID-19 DiseaseAbstract
Background: cardiac complications due to SARS-CoV-2 virus have caused great affections in the adult population. Post infection complications include pulmonary and extrapulmonary complications, also known as "Post COVID-19 Syndrome"; these patients are approached by complementary examinations since they present a non-specific clinical picture.
Aim: to determine the main cardiac complications in patients post COVID-19 infection.
Methods: a bibliographic search of articles published in the Pubmed database was performed.
Results: acute cardiac injury was one of the most prevalent; other notable symptoms were arrhythmias, heart failure and, to a lesser extent, disseminated intravascular coagulation. Patients who develop shock after coronavirus infection are the result of myocardial injury in addition to other risk factors such as a history of elevated cardiac biomarkers and stay in intensive care units due to the viral disease. Another clinical manifestation with high prevalence in these patients is dyspnea, a symptom that is closely related to an intolerance to physical exertion and fatigue evidenced in periods of time less than 12 months after infection.
Conclusions: cardiac complications were arrhythmias, acute coronary syndrome, heart failure, shock and disseminated intravascular coagulation; manifesting mainly with fever and dyspnea, also the most vulnerable patients were those with different comorbidities
References
1. Quiroz Carrillo CG, Pareja Cruz A, Valencia Ayala E, Enriquez Valencia YP, De Leon Delgado J, Aguilar Ramirez P, et al. Un nuevo coronavirus, una nueva enfermedad: COVID-19. Horiz Méd Lima 2020;20(2): e1208. http://dx.doi.org/10.24265/horizmed.2020.v20n2.11.
2. Cortellezzi Z, González V. Alteraciones cardiovasculares agudas y síndrome post COVID-19. Salud Mil 2021;40(2):e401-e401. https://doi.org/10.35954/SM2021.40.2.4.e401.
3. Trujillo CHS. SECCION IX. Síndrome Post COVID-19: complicaciones tardías y rehabilitación. Infectio 2021;25(4):290-344. https://doi.org/10.22354/in.v25i4.979.
4. Venegas I. S, Valdés O. R, Palacios M. S, Soto F. S, Schiappacasse F. G, Vidal A. H, et al. Hallazgos y complicaciones extrapulmonares en pacientes con neumopatía Covid-19: Experiencia local y revisión de la literatura. Rev Chil Radiol 2021;27(2):66-75. http://dx.doi.org/10.4067/S0717-93082021000200066.
5. Pecho-Silva S, Arteaga-Livias K, Bazán-Concha BE, Navarro-Solsol AC. Complicaciones extrapulmonares de la enfermedad por COVID-19. Rev Peru Investig En Salud 2020;4(4):183-9. https://doi.org/10.35839/repis.4.4.775.
6. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020;109(5):531-8. https://doi.org/10.1007/s00392-020-01626-9.
7. Patel U, Malik P, Mehta D, Rajput P, Shrivastava M, Naveed M, et al. Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 2021;30(7):105805. https://doi.org/10.1016%2Fj.jstrokecerebrovasdis.2021.105805.
8. Zhao YH, Zhao L, Yang XC, Wang P. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis. Rev Cardiovasc Med 2021;22(1):159-65. https://doi.org/10.31083/j.rcm.2021.01.238.
9. Zhong Z, Li H, Zhu J, Ji P, Li B, Pang J, et al. Clinical characteristics of 2,459 severe or critically ill COVID-19 patients: A meta-analysis. Medicine (Baltimore) 2021;100(5):e23781. https://doi.org/10.1097%2FMD.0000000000023781.
10. Vakili K, Fathi M, Pezeshgi A, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, et al. Critical complications of COVID-19: A descriptive meta-analysis study. Rev Cardiovasc Med 2020;21(3):433-42. http://doi.org/10.31083/j.rcm.2020.03.129.
11. Jafari-Oori M, Moradian ST, Ebadi A, Jafari M, Dehi M. Incidence of cardiac complications following COVID-19 infection: An umbrella meta-analysis study. Heart Lung J Crit Care 2022;52:136-45. https://doi.org/10.1016/j.hrtlng.2022.01.001.
12. Szarpak L, Filipiak KJ, Skwarek A, Pruc M, Rahnama M, Denegri A, et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis. Cardiol J 2022;29(1):33-43. https://doi.org/10.1111%2Fjce.14770.
13. Armas KSE, Mola KP, Cuenca MB. El sistema cardiovascular y el daño inducido por la infección por coronavirus-2. Rev Cuba Med. 2021;60(2):1-9.
14. Jiménez ELS, Ulloa LVM, Álava JUG, Carrera PES. Prevalencia de enfermedades del sistema cardiovascular asociadas al covid 19. RECIMUNDO 2022;6(2):558-65. https://doi.org/10.26820/recimundo/6.(2).abr.2022.558-565.
15. Li J, He X, Yuan Yuan null, Zhang W, Li X, Zhang Y, et al. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Am J Infect Control 2021;49(1):82-9. https://doi.org/10.1016/j.ajic.2020.06.008.
16. Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2022;28(5):657-66. https://doi.org/10.1016/j.cmi.2022.01.014.
17. Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020;24:389. https://doi.org/10.1186/s13054-020-03022-1
Published
Issue
Section
License
Copyright (c) 2022 Lisseth Tatiana Quiridunbay Pasato , Carlos Enrique Flores Montesinos , Bryan Patricio Ortiz Encalada (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
